Is a complete BNGO research report available?

No complete published report is available for Bionano Genomics, Inc. (BNGO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Bionano Genomics, Inc. (BNGO)

NASDAQ: BNGO · USD

$1.11

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BNGO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	12.7M
Revenue (ttm)	28.7M
Net income (ttm)	-31.6M
EPS (ttm)	-$4.20
Shares out	11.5M
Volume	101,109
Beta	1.62
Price target	$5.00	+350.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 28.7M
Net income (ttm): -31.6M
EPS (ttm): -$4.20
Market cap: 12.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BNGO indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001411690
Company name	Bionano Genomics, Inc.
Country	United States
Country code	US
Cusip	09075F404
Employees	97
Employees Change	-3%
Employees Change Percent	-3
Enterprise value	$15.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
Industry PE	64.22
Industry PE Fwd	20.47
IPO Date	2018-08-21
Isin	US09075F4046
Last refreshed	2026-07-25
Market cap	$12.7M
Market cap category	Nano-Cap
Price	$1.11
Price currency	USD
Rev Per Employee	296,268.04x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	3826
Symbol	BNGO
Website	https://bionano.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-246.95%
EV Sales Forward	0.45x
EV/Sales	0.54x
FCF yield	-150.82%
P/B ratio	0.33x
P/S ratio	0.45x
PS Forward	0.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-114.03%
EBITDA Margin	-80.6%
Gross margin	46.97%
Gross Profit	$13.5M
Gross Profit Growth	2,632.59%
Gross Profit Growth Q	10.69%
Gross Profit Growth3 Y	23.57%
Gross Profit Growth5 Y	30.72%
Net Income	$-31.6M
Net Income Growth Years	2%
Pretax Margin	-109.7%
Profit Margin	-109.95%
Profit Per Employee	$-325,732
ROA	-28.6
Roa5y	-28.72
ROCE	-75.2
ROE	-73.78
Roe5y	-91.04
ROIC	-33.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-68.31%
Cagr3y	-85.41%
Cagr5y	-80.13%
EPS Growth Quarters	10
EPS Growth Years	2
Revenue Growth	0.96x
Revenue Growth Q	3.56x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.89x
Revenue Growth5 Y	22.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.4
Assets	$64.8M
Cash	$14.4M
Current Assets	$39M
Current Liabilities	$21.2M
Debt	$17M
Debt Equity	$0.45
Equity	$37.5M
Interest Coverage	-115
Liabilities	$27.3M
Long Term Assets	$25.8M
Long Term Liabilities	$6.1M
Net Cash	$-2.6M
Net Cash By Market Cap	$-20.39
Net Debt Equity	$0.07
Tangible Book Value	$34.5M
Tangible Book Value Per Share	$3.06
WACC	6.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.84
Inventory Turnover	2.05
Net Working Capital	$14.4M
Quick ratio	0.87
Working Capital	$17.7M
Working Capital Turnover	$1.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-335.79%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-68.29%
200-day SMA	1.38
3Y total return	-99.69%
50-day SMA	1.18
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.97%
All Time High	9,414
All Time High Change	-99.99%
All Time High Date	2021-02-16
All Time Low	1.06
All Time Low Change	4.72%
All Time Low Date	2026-02-05
ATR	0.04
Beta	1.62
Beta1y	1.02
Beta2y	1.55
Ch YTD	-27.45
High	1.15
High52	5.5
High52 Date	2025-09-11
High52ch	-79.82%
Low	1.11
Low52	1.06
Low52 Date	2026-02-05
Low52ch	4.72%
Ma50ch	-5.53%
Premarket Change Percent	1.8
Premarket Price	$1.13
Price vs 200-day SMA	-19.45%
RSI	41.5
RSI Monthly	33.3
RSI Weekly	36.29
Sharpe ratio	-1.02x
Sortino ratio	-1.25
Total Return	-335.79%
Tr YTD	-27.45
Tr1m	-3.48%
Tr1w	-3.48%
Tr3m	-8.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	0
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.68
Earnings Revenue Estimate	7,476,000x
Earnings Revenue Estimate Growth	11.04x
Operating Income	$-32.8M
Operating margin	-114
Price target	$5
Price Target Change	$350

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,342,497%
Float Percent	90.13%
Net Borrowing	-3,450,000
Shares Insiders	0.03%
Shares Institutions	11.84%
Shares Out	11,475,000
Shares Qo Q	6.66%
Shares Yo Y	335.79%
Short Float	11.19%
Short Ratio	7.84
Short Shares	10.09

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-22.9M
Average Volume	120,363.55x
Bv Per Share	3.32
Ch1m	-3.48
Ch1w	-3.48
Ch1y	-68.29
Ch3m	-8.26
Ch3y	-99.69
Ch5y	-99.97
Ch6m	-31.48
Change	0%
Change From Open	-0.89
Close	1.11
Days Gap	0.9
Depreciation Amortization	9,403,000
Dollar Volume	112,231
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-32.8M
EBITDA	$-23.2M
EPS	$-4.2
F Score	4
FCF	$-19.3M
FCF EV Yield	-125.28x
FCF Per Share	$-1.68
Financing CF	13,805,000
Fiscal Year End	December
Founded	2,003
Income Tax	$70,000
Investing CF	6,776,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2025-01-27
Last Split Type	Reverse
Last10k Filing Date	2026-03-23
Ma150	1.25
Ma150ch	-11.34%
Ma20	1.15
Ma20ch	-3.23%
Net CF	1,287,000
Next Earnings Date	2026-08-13
Open	1.12
Optionable	No
Position In Range	11.11
Ppne	20,146,000
Pre Close	1.11
Price Date	2026-07-24
Ptbv Ratio	0.37
Relative Volume	0.84x
Revenue	28,738,000x
SBC By Revenue	12.59x
Share Based Comp	3,617,000
Tax By Revenue	0.24x
Tr6m	-31.48%
Us State	California
Volume	101,109
Z Score	-16.31

Bionano Genomics, Inc. (BNGO)

Coverage state: Market snapshot only — no published research

Generate the first BNGO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BNGO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BNGO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BNGO

Frequently asked questions